Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald H Sitte

Showing results (71-80 of 186) with videos related to

Pageof 19
Sort By:
Scientific Reports|October 6, 2020
Saturation transfer difference NMR on the integral trimeric membrane transport protein GltPh determines cooperative substrate bindingJenny L Hall, Azmat Sohail, Eurico J Cabrita, et al.
Frontiers in Pharmacology|June 9, 2020
Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of <i>In Vitro</i> Methods to Assess the Potency of Drugs That Target Monoamine TransportersMarija Ilic, Marion Holy, Kathrin Jaentsch, et al.
The Journal of Biological Chemistry|January 19, 2017
Occupancy of the Zinc-binding Site by Transition Metals Decreases the Substrate Affinity of the Human Dopamine Transporter by an Allosteric MechanismYang Li, Felix P Mayer, Peter S Hasenhuetl, et al.
Biochimica Et Biophysica Acta|November 1, 2008
A membrane network of receptors and enzymes for adenine nucleotides and nucleosidesKlaus Schicker, Simon Hussl, Giri K Chandaka, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 21, 2008
Sec24- and ARFGAP1-dependent trafficking of GABA transporter-1 is a prerequisite for correct axonal targetingVeronika Reiterer, Susanne Maier, Harald H Sitte, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 11, 2008
Anomalous dopamine release associated with a human dopamine transporter coding variantMichelle S Mazei-Robison, Erica Bowton, Marion Holy, et al.
British Journal of Pharmacology|November 21, 2013
A quantitative model of amphetamine action on the 5-HT transporterWalter Sandtner, Diethart Schmid, Klaus Schicker, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 9, 2025
Rescue of Epilepsy-Associated Mutations of the Highly Conserved Glycine Residue 443 in the Human GABA Transporter 1Nikita Shah, Vasylyna Kovalchuk, Rocco Zerlotti, et al.
Molecular Pharmacology|September 17, 2009
Subtype-specific differences in corticotropin-releasing factor receptor complexes detected by fluorescence spectroscopyLaura Milan-Lobo, Ingrid Gsandtner, Erwin Gaubitzer, et al.
The European Journal of Neuroscience|October 15, 2016
Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implicationsHarald H Sitte, Christian Pifl, Ali H Rajput, et al.
Pageof 19

Showing results (71-80 of 186) with videos related to

Sort By:
Pageof 19
Scientific Reports|October 6, 2020
Saturation transfer difference NMR on the integral trimeric membrane transport protein GltPh determines cooperative substrate bindingJenny L Hall, Azmat Sohail, Eurico J Cabrita, et al.
Frontiers in Pharmacology|June 9, 2020
Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of <i>In Vitro</i> Methods to Assess the Potency of Drugs That Target Monoamine TransportersMarija Ilic, Marion Holy, Kathrin Jaentsch, et al.
The Journal of Biological Chemistry|January 19, 2017
Occupancy of the Zinc-binding Site by Transition Metals Decreases the Substrate Affinity of the Human Dopamine Transporter by an Allosteric MechanismYang Li, Felix P Mayer, Peter S Hasenhuetl, et al.
Biochimica Et Biophysica Acta|November 1, 2008
A membrane network of receptors and enzymes for adenine nucleotides and nucleosidesKlaus Schicker, Simon Hussl, Giri K Chandaka, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 21, 2008
Sec24- and ARFGAP1-dependent trafficking of GABA transporter-1 is a prerequisite for correct axonal targetingVeronika Reiterer, Susanne Maier, Harald H Sitte, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 11, 2008
Anomalous dopamine release associated with a human dopamine transporter coding variantMichelle S Mazei-Robison, Erica Bowton, Marion Holy, et al.
British Journal of Pharmacology|November 21, 2013
A quantitative model of amphetamine action on the 5-HT transporterWalter Sandtner, Diethart Schmid, Klaus Schicker, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 9, 2025
Rescue of Epilepsy-Associated Mutations of the Highly Conserved Glycine Residue 443 in the Human GABA Transporter 1Nikita Shah, Vasylyna Kovalchuk, Rocco Zerlotti, et al.
Molecular Pharmacology|September 17, 2009
Subtype-specific differences in corticotropin-releasing factor receptor complexes detected by fluorescence spectroscopyLaura Milan-Lobo, Ingrid Gsandtner, Erwin Gaubitzer, et al.
The European Journal of Neuroscience|October 15, 2016
Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implicationsHarald H Sitte, Christian Pifl, Ali H Rajput, et al.
Pageof 19